Rhea Coler | Biotechnology | Research Hypothesis Excellence Award

Published on by Research Hypothesis

Prof. Rhea Coler | Biotechnology | Research Hypothesis Excellence Award

Principal Investigator at Seattle Children’s Research Institute / University of Washington, United States

Dr. Rhea Nadine Coler is a distinguished immunologist and global health researcher with over two decades of impactful contributions to infectious disease research, vaccine development, and translational immunology. Currently serving as a Professor at the University of Washington School of Medicine and Senior Investigator at Seattle Children’s Research Institute, she has held multiple leadership roles, including Vice President of Research and Development at IDRI and PAI Life Sciences. Her career is marked by significant involvement in international health organizations such as the World Health Organization, Gates Medical Research Institute, and GSK Vaccines Institute for Global Health. A committed educator and mentor, Dr. Coler has guided numerous Ph.D. candidates and postdoctoral fellows while leading curriculum development in global health. She is also a strong advocate for diversity, equity, and inclusion, spearheading anti-racism initiatives within her institution. With editorial roles in journals like Frontiers in Immunology and a long-standing record of NIH grant reviews, Dr. Coler exemplifies research excellence, leadership, and dedication to advancing global health.

Professional Profile 

🎓 Educational Background of Dr. Rhea Coler

Dr. Rhea Coler’s academic journey reflects a deep commitment to biomedical sciences and global health. She began her education at St. Joseph’s Convent in Trinidad, completing both her GCE Ordinary and Advanced Levels. She earned her B.Sc. in Physiology from McGill University in Montreal, Canada, laying the foundation for her future in biomedical research. She went on to complete her M.Sc. in Medical Parasitology at the prestigious London School of Hygiene and Tropical Medicine in the UK. Further strengthening her research credentials, she pursued graduate-level studies in Pathobiology and Epidemiology at Washington State University. Dr. Coler culminated her formal education with a Ph.D. in Pathobiology from the University of Washington, where her research was conducted at Corixa Corporation. This rich and international academic background has uniquely positioned her to lead groundbreaking work in infectious diseases and immunology.

💼 Professional Experience of Dr. Rhea Coler

Dr. Rhea Coler has built an exemplary career at the intersection of academic research, biotechnology, and global health. She began as a Post-doctoral Scientist at the Infectious Disease Research Institute (IDRI), eventually advancing through pivotal roles such as Scientist, Director of Preclinical Biology, and ultimately Senior Vice President of Translational Research. Concurrently, she held leadership roles at PAI Life Sciences Inc. as Vice President of Research and Development. In academia, Dr. Coler has served as an Affiliate Professor and now as a Professor of Pediatrics in Infectious Diseases at the University of Washington School of Medicine, as well as a Senior Investigator at the Seattle Children’s Research Institute. Her extensive experience also includes editorial responsibilities, NIH grant reviews, and international advisory work, reflecting her far-reaching influence in infectious disease research and vaccine development.

🔬 Research Interests of Dr. Rhea Coler

Dr. Rhea Coler’s research is centered on infectious diseases, immunology, and vaccine development, with a strong focus on host-pathogen interactions and immune responses to neglected tropical diseases and emerging pathogens. Her work emphasizes the design and preclinical development of novel vaccine candidates for diseases such as tuberculosis, leishmaniasis, and other parasitic and bacterial infections. She is particularly interested in understanding protective immune mechanisms, identifying biomarkers of vaccine efficacy, and advancing adjuvant technologies to enhance immune responses. Dr. Coler is also engaged in translational immunology, bridging laboratory discoveries with real-world applications through global health partnerships and clinical research collaborations. Her goal is to develop safe, effective, and accessible vaccines to improve health outcomes in vulnerable populations worldwide.

🏆 Awards and Honors of Dr. Rhea Coler

Dr. Rhea Coler has received numerous prestigious awards and honors that reflect her outstanding contributions to biomedical research and global health. Early in her career, she was recognized for her master’s research at the London School of Hygiene and Tropical Medicine, earning a departmental award and a Halley Stewart Foundation Research Grant. She was later awarded a highly competitive NIH Pre-doctoral Biotechnology Fellowship and continued to earn NIH/NIAID fellowships during both her doctoral and postdoctoral training, highlighting her early promise in infectious disease research. Her work has consistently attracted national recognition, leading to her selection as a reviewer, panelist, and chair for major NIH and global grant review panels. In addition, she has been honored by organizations such as the ARCS Foundation, the New York Community Trust Heiser Program for Research, and international institutions for her leadership in science and commitment to mentoring the next generation of researchers.

✅ Conclusion

Dr. Rhea Coler is an outstanding candidate for the Research Hypothesis Excellence Award. Her career demonstrates sustained excellence in hypothesis-driven translational research, leadership in global health innovation, mentoring, and a deep commitment to scientific integrity and DEI values.

🧾 Publication List of Dr. Rhea Coler

  1. Title: Evaluation of host immune responses to Mycobacteriophage Fionnbharth by route of delivery
    Authors: [Authors not listed here, as per source]
    Journal: Virology Journal
    Year: 2025
    Citations: 0

  2. Title: Comparative study on the virulence of mycobacteriophages
    Authors: [Authors not listed here]
    Journal: Journal of Virology
    Year: 2025
    Citations: 0

  3. Title: Characterizing TLR4 agonist EmT4™ as an anti-Mycobacterium tuberculosis vaccine adjuvant
    Authors: [Authors not listed here]
    Journal: Immunohorizons
    Year: 2025
    Citations: 0

  4. Title: DEVELOPMENT AND CONCORDANCE OF BINDING AND NEUTRALIZING ASSAYS TO DETERMINE SARS-COV-2 ANTIBODY ACTIVITY IN HUMAN MILK
    Authors: [Authors not listed here]
    Journal: Pathogens and Immunity
    Year: 2025
    Citations: 0

  5. Title: The Sm14+GLA-SE Recombinant Vaccine Against Schistosoma mansoni and S. haematobium in Adults and School Children: Phase II Clinical Trials in West Africa
    Authors: [Authors not listed here]
    Journal: Vaccines
    Year: 2025
    Citations: 0

  6. Title: Backtranslation of human RNA biosignatures of tuberculosis disease risk into the preclinical pipeline is condition dependent
    Authors: [Authors not listed here]
    Journal: mSphere
    Year: 2025
    Citations: 0

  7. Title: Enhanced D614G and Omicron Variants Antibody Persistence in Infants at 2 Months of Age Following Maternal mRNA Booster Vaccination During Pregnancy or Postpartum
    Authors: [Authors not listed here]
    Journal: Pediatric Infectious Disease Journal
    Year: 2024
    Citations: 1

  8. Title: Maternal COVID-19 Vaccination and Prevention of Symptomatic Infection in Infants
    Authors: [Authors not listed here]
    Journal: Pediatrics
    Year: 2024
    Citations: 11

  9. Title: Recombinase-based amplification coupled with lateral flow chromatography for the specific and sensitive detection and identification of Leishmania major in cutaneous leishmaniasis patients
    Authors: [Authors not listed here]
    Journal: Frontiers in Microbiology
    Year: 2024
    Citations: 1

  10. Title: Understanding the development of tuberculous granulomas: insights into host protection and pathogenesis, a review in humans and animals
    Authors: [Authors not listed here]
    Type: Review
    Year: [Not mentioned explicitly, assumed 2024/2025]
    Citations: 1

Jwee Chiek Er | Biology and Life Sciences | Pioneer Researcher Award

Published on by Research Hypothesis

Jwee Chiek Er | Biology and Life Sciences | Pioneer Researcher Award

Researcher, Norwegian Veterinary Institution, Norway

Dr. Jwee Chiek Er is a distinguished veterinary epidemiologist and researcher dedicated to advancing animal health. 🐖📈 Since 2007, he has worked full-time at the Norwegian Veterinary Institute, focusing on epidemiology and bioinformatics. 🇳🇴🔬 He also serves part-time as a church servant at Uranienborg Menighet since 2020. ⛪ Previously, Dr. Er contributed significantly to veterinary inspection in Singapore’s pig and poultry slaughterhouses (1991–2006) and served as a Captain in the Singapore Armed Forces (1989–1991). 🛡️🏥 With a Ph.D. from the University of Life Sciences, Norway, an MPVM from UC Davis, and a BVSc from the University of Queensland, Dr. Er’s career blends scientific excellence with public service. 🎓🌍 His pioneering research on influenza A(H1N1)pdm09 virus infection in pigs has had lasting impacts on veterinary public health. 🦠📖 A committed scholar with 14 peer-reviewed publications, Dr. Er exemplifies the qualities honored by the Pioneer Researcher Award. 🏆✨

Publication  Profile

Orcid

Education 

Dr. Jwee Chiek Er holds a rich academic background dedicated to veterinary science and epidemiology. 🎓🐾 He earned his Ph.D. in 2006 from the University of Life Sciences, Oslo, Norway, presenting a landmark thesis on epidemiological studies of influenza A(H1N1)pdm09 virus infections in Norwegian pigs. 🇳🇴📚 He pursued his Master’s in Preventive Veterinary Medicine (MPVM) at the prestigious University of California, Davis, USA, graduating in 2000 with a focus on Veterinary Epidemiology. 🇺🇸📊 Dr. Er began his academic journey with a Bachelor of Veterinary Science (BVSc) from the University of Queensland, Australia, in 1989, grounding him firmly in veterinary practice. 🇦🇺🩺 His education reflects a lifelong commitment to enhancing animal health and advancing veterinary epidemiology through global learning experiences, interdisciplinary knowledge, and applied research, making him a fitting nominee for the Pioneer Researcher Award. 🏅🌟

Experience 

Dr. Jwee Chiek Er’s professional journey reflects outstanding dedication across diverse fields. 🌟 From 2007 onwards, he has been a full-time researcher at the Norwegian Veterinary Institute, specializing in epidemiology and bioinformatics. 🐷📊 In 2020, he also took on part-time service as a church servant at Uranienborg Menighet, den norsk luthersk kirke. ⛪ Before his research career, Dr. Er served in Singapore’s civil service (1991–2006), ensuring veterinary inspection and public health in pig and poultry slaughterhouses. 🐔🔍 He started his career in national service, where he rose to the rank of Captain in the Singapore Armed Forces as a logistics officer (1989–1991). 🎖️🚛 These extensive experiences demonstrate his leadership, scientific expertise, and commitment to public welfare. His professional background embodies the spirit of perseverance and innovation celebrated by the Pioneer Researcher Award. 🏅📈

Awards and Honors 

Dr. Jwee Chiek Er’s career is a testament to persistent excellence and leadership. 🌟 Although specific award listings were not detailed, his achievements themselves reflect high recognition in the veterinary science community. 🐾📈 His Ph.D. thesis and impactful peer-reviewed publications have significantly advanced knowledge of influenza epidemiology in pig populations, demonstrating award-worthy innovation. 🦠🔬 His pioneering surveillance work on influenza A(H1N1)pdm09 infections in Norway greatly contributed to national animal health strategies. 🇳🇴🐖 Furthermore, Dr. Er’s role in public veterinary service in Singapore and his distinguished service in the Singapore Armed Forces earned him respect and authority early in his career. 🎖️🌏 Nomination for the Pioneer Researcher Award is a fitting tribute to his lifelong dedication to animal health, epidemiological innovation, and scientific leadership. 🏅📚 His work bridges practice and research, influencing veterinary policies across nations. 🌐✨

Research Focus 

Dr. Jwee Chiek Er’s research centers on the epidemiology of infectious diseases in animal populations, with a strong focus on influenza A(H1N1)pdm09 virus in pigs. 🐖🦠 His studies analyze infection patterns, serosurveillance, and economic impacts on animal health, providing essential insights for disease control and public health policy. 📊🛡️ Using bioinformatics and mathematical modeling, such as discrete-time Markov Chain modeling, he projects disease prevalence and evaluates herd-level interventions. 📈🖥️ His research also explores serological cross-reactivity between influenza strains, crucial for improving diagnostic and surveillance systems. 🧬🔍 Through longitudinal studies at boar testing stations and comprehensive serological surveys, Dr. Er has significantly advanced understanding of viral behavior in livestock. 📑📈 His interdisciplinary approach integrating epidemiology, economics, and computational tools highlights him as a pioneer in veterinary research. 🏆🔬 His work supports healthier livestock systems and contributes to global food security. 🌍🍖

Publications Top Notes

  • 📄 “Adverse Effects of Influenza A(H1N1)Pdm09 Virus Infection on Growth Performance of Norwegian Pigs – a Longitudinal Study at a Boar Testing Station” (BMC Vet Res, 2014)

  • 📄 “Occurrence and Spread of Influenza A(H1N1)Pdm09 Virus Infection in Norwegian Pig Herds Based on Active Serosurveillance from 2010 to 2014” (Epidemiol Infect, 2016)

  • 📄 “Production Impact of Influenza A(H1N1)Pdm09 Virus Infection on Fattening Pigs in Norway” (J Anim Sci, 2016)

  • 📄 “Longitudinal Projection of Herd Prevalence of Influenza A(H1N1)Pdm09 Virus Infection in the Norwegian Pig Population by Discrete-Time Markov Chain Modelling” (Infectious Disease Reports, 2021)

  • 📄 “Antibodies of Influenza A(H1N1)Pdm09 Virus in Pigs’ Sera Cross-React with Other Influenza A Virus Subtypes: A Retrospective Epidemiological Interpretation of Norway’s Serosurveillance Data from 2009–2017” (Epidemiology and Infection, 2020)

  • 📄 “A Survey of Skin Neoplasms in Dogs from the Brisbane Region” (Aust Vet J, 1989)

David Nwikwe | Biology and Life Sciences | Best Researcher Award

Published on by Research Hypothesis

David Nwikwe | Biology and Life Sciences | Best Researcher Award

Dr David Nwikwe, Kings University, Nigeria, Nigeria

Dr. David Nwikwe 🎓 is a passionate biochemist specializing in toxicology, pharmacology, and antioxidant research. He earned his Ph.D. (2022), M.Sc. (2016), and B.Sc. (2013) in Biochemistry from the University of Ilorin 🇳🇬. Currently a Lecturer at Kings University and a Volunteer Instructor at the University of the People 🌍, he has published extensively on hepatotoxicity, antimalarial activity, and oxidative stress. Dr. Nwikwe has received multiple excellence awards for research and peer reviewing 🏅. His NGO work focuses on health advocacy, disaster management, and youth development, reflecting his commitment to science and community well-being ❤️.

Publication Profile

Google Scholar

Academic Excellence

Dr. David Nwikwe holds a Ph.D. in Biochemistry 🎓, distinguished by the prestigious Outstanding Ph.D. Graduate Award 🏆. His academic journey reflects unwavering dedication, progressing from a B.Sc. to a Ph.D. at the University of Ilorin 📚. Driven by a passion for scientific excellence 🔬, Dr. Nwikwe has demonstrated exceptional commitment to research and academic growth 🌱. His achievements highlight not only his intellectual prowess but also his perseverance in the dynamic field of biochemistry ⚗️. With a strong foundation in scientific inquiry and innovation, he continues to inspire future scholars and contribute significantly to biochemical research 🌍.

Teaching and Mentorship

Dr. David Nwikwe is a dedicated academic, serving as a Lecturer at Kings University and an Instructor at the University of the People 🎓. He actively mentors undergraduates, fostering their academic growth while efficiently managing departmental affairs 📚. Dr. Nwikwe’s leadership shines through his pivotal role in coordinating NUC accreditation processes ✅ and supervising various academic activities. His commitment to excellence and mentorship reflects his passion for shaping future scholars 🌟. Through his dynamic roles, he contributes significantly to academic development, inspiring students and colleagues alike 🌍.

Global Impact and Community Engagement

Dr. David Nwikwe is dedicated to making a societal impact beyond academics 🌍📚. His active involvement in NGO projects funded by international bodies like the EU and Global Fund Canada highlights his commitment to global development 🤝🌐. Dr. Nwikwe has contributed to initiatives focused on malaria control 🦟🚫, gender-based issues ⚧️💪, and adolescent health 👩‍⚕️🧑‍⚕️, reflecting a holistic approach to research and community well-being. His work bridges the gap between scientific research and real-world challenges, promoting health, equality, and sustainable development 🌱❤️.

Honors and Awards

Dr. David Nwikwe, a distinguished scholar from the Faculty of Life Sciences, University of Ilorin, received the Award for Outstanding PhD Graduate in 2023 🏆. His leadership journey began early, serving as Class Monitor at Ade-Oshodi Memorial Baptist Primary School (1994-1999) 📚 and later as Senior Prefect and Class Monitor at Okesuna High School, Lagos (1999-2005) 🎓. He won the Best Student Award in the “Spelling Bee” (Zonal Secondary School Category) organized by New Era Foundation in 2005 🐝. David continued his leadership roles as Class Representative during his National Diploma at Kwara State Polytechnic (2007-2009) and M.Sc. Biochemistry program at the University of Ilorin (2014-2016) 🧪.

Research Focus

Dr. David Nwikwe’s research focuses on toxicology, pharmacology, and natural product studies 🧪🌿. His work explores the hepatotoxic effects of drugs like Synriam™ 🏥, the toxicological impact of nanoparticles in water systems 💧⚗️, and the antioxidant and anti-inflammatory properties of plant extracts such as Syzygium aromaticum and Capsicum frutescens 🌱🩺. He also investigates antimalarial activities, oxidative stress reduction, and the modulatory effects of substances like ethanol with Nicotiana tabacum and Cannabis sativa 🧬🧠. His multidisciplinary approach blends in-vivo, in-silico, and molecular docking studies 🔬💻, contributing significantly to biomedical and environmental health sciences 🌍.

Publication Top Notes

Assessment of hepatotoxicity effects of long term administration of SynriamTM in rats

Toxicological assessment of ZnO-Vernonia amygdalina nanoparticle-treated Asa River water in albino rats

ANTIOXIDANT AND ANTI-INFLAMMATORY POTENTIALS OF METHANOL EXTRACT OF SYZYGIUM AROMATICUM L. FLOWER BUDS ON FORMALIN-INDUCED PAW OEDEMA IN RATS

Study on Antimalarial Activity of Capsicum frutescens L. Fruit Extracts during Early and Established Plasmodium Infection in Mice

Evaluation of Cryptolepis sanguinolenta Stem Ethanol Extract in Animal Models

Assessing the Oxidative Stress Reducing Potential of Spilanthes filicaulis (Schumach & Thonn) Ethyl-Acetate Sub-fractions on Plasmodium berghei Infected …

Effects of sprouting on the antioxidant potentials of garlic (Allium sativum L.) And onions (Allium cepa L.)

Modulatory Effects of Ethanol with Nicotiana Tabacum and Cannabis Sativa on Markers of Brain Function and Haematological Parameters: In-Vivo and In-Silico Approach

4-Nitrobenzoic Acid and Azaperone from Thaumatococcus daniellii Leaves as Potential Green Preservative Against Fungal Infestation of Cereals with Molecular Docking Studies